ArticleBMC cancer2023

A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer.

Nicolas Roussot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.